It produces a weight loss, on average, of about 3 kg (de Silva VA et al, BMC Psychiatry 2016;16(1):341) or about a 3% reduction in body weight, compared to a 1% reduction with placebo (Jarskog LF et al, Am J Psychiatry 2013;170(9):10321040)
In addition to government programs, companies are also broadening their benefits to include coverage of GLP-1 medications
Those taking thyroid replacement therapy (levothyroxine) may experience altered absorption or metabolism when starting GLP-1 agonists because these medications slow gastric emptying
[PubMed] [Google Scholar] 54.Dube K.N., Thomas T.M., Munshaw S., Rohling M., Riley P.R., Smart N
Galloway, D.C., Blacke, D.G., Shepherd, A.G
Learn more about the GHK-Cu peptide here